| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Early Development
1 company
Lesage Anne is a Chief Early Development at PHVS. Recent filings cover 0 purchases and 19 sales. Those positions are worth an estimated $2.8M at current prices.
Our model assigns Lesage Anne a below-average insider score of 48/100, based on 7 past trades. On a 3-month view, 42.9% of the rated trades came out ahead, averaging -6.0% over three months.
Lesage Anne's largest disclosed position is in PHVS as Chief Early Development, worth about $2.8M. The recent filings there lean toward selling, a net 193,772 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | PHVS Pharvaris N.V. | Chief Early Development | Sell | 20,000 | $38.27 | $765,466.00 | -21.3% | - | - | |
| Sep 10, 2026 | PHVS Pharvaris N.V. | Chief Early Development | Sale+OE10b5-1 | 30,000 | $38.30 | $1,149,084.00 | -34.7% | - | - | |
| Jun 30, 2026 | PHVS Pharvaris N.V. | Chief Early Development | Sale+OE10b5-1 | 76,172 | $35.39 | $2,695,452.13 | -33.3% | -7.7% | - | |
| Jun 25, 2026 | PHVS Pharvaris N.V. | Chief Early Development | Sale+OE10b5-1 | 4,600 | $35.12 | $161,560.28 | -2.4% | -0.7% | - | |
| Apr 30, 2026 | PHVS Pharvaris N.V. | Chief Early Development | Sale+OE10b5-1 | 48,300 | $30.23 | $1,459,970.16 | -26.5% | +5.2% | - | |
| Apr 23, 2026 | PHVS Pharvaris N.V. | Chief Early Development | Sale+OE10b5-1 | 14,700 | $30.05 | $441,725.60 | -20.7% | +25.9% | - |